Skip to main content

Table 3 Multivariate survival analysis of overall survival and disease-free survival in 120 patients with ESCC

From: Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma

Features Overall survival Disease-free survival
  Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
Primary tumor (T3 + T4/T1 + T2) 1.746 (1.104 to 2.762) 0.017a 1.516 (1.005 to 2.289) 0.048a
TNM stage (III/I + II) 16.347 (8.560 to 31.215) <0.001a 11.729 (6.448 to 21.335) <0.001a
Lymph node metastases (−/+) 0.838 (0.534 to 1.315) 0.442 0.906 (0.596 to 1.375) 0.642
HSPA2 expression (positive/negative) 2.210 (1.101 to 4.435) 0.026a 2.115 (1.222 to 3.661) 0.007a
  1. aP values considered statistically significant at <0.05. CI, confidence interval; ESCC, esophageal squamous cell carcinoma; G, grade; N, lymph node metastases; T, primary tumor.